Zacks Research Predicts Masimo’s Q1 Earnings (NASDAQ:MASI)

Masimo Co. (NASDAQ:MASI) – Zacks Research lifted their Q1 2025 EPS estimates for shares of Masimo in a report issued on Wednesday, February 19th. Zacks Research analyst I. Bandyopadhyay now expects that the medical equipment provider will post earnings of $0.91 per share for the quarter, up from their prior estimate of $0.89. The consensus estimate for Masimo’s current full-year earnings is $4.10 per share. Zacks Research also issued estimates for Masimo’s Q3 2025 earnings at $1.01 EPS, Q4 2025 earnings at $1.34 EPS, FY2025 earnings at $4.25 EPS, Q3 2026 earnings at $1.17 EPS, Q4 2026 earnings at $1.45 EPS and FY2026 earnings at $4.89 EPS.

Other equities research analysts have also issued research reports about the stock. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research note on Wednesday, January 22nd. Wells Fargo & Company boosted their price objective on shares of Masimo from $171.00 to $193.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 11th. Raymond James upped their target price on shares of Masimo from $170.00 to $194.00 and gave the stock an “outperform” rating in a research note on Friday, December 27th. Piper Sandler upped their target price on shares of Masimo from $180.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 18th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $190.00 target price (up previously from $170.00) on shares of Masimo in a research note on Friday, November 22nd. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $191.40.

Masimo Trading Down 4.1 %

Shares of MASI opened at $169.96 on Friday. The firm’s 50-day moving average price is $172.78 and its 200-day moving average price is $152.03. The firm has a market capitalization of $9.10 billion, a price-to-earnings ratio of 117.21 and a beta of 1.02. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. Masimo has a 1-year low of $101.61 and a 1-year high of $184.51.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the stock. Jones Financial Companies Lllp purchased a new stake in Masimo during the fourth quarter valued at approximately $27,000. UMB Bank n.a. lifted its position in Masimo by 180.9% during the fourth quarter. UMB Bank n.a. now owns 191 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 123 shares during the last quarter. Trust Co. of Vermont purchased a new stake in shares of Masimo in the fourth quarter valued at $33,000. Blue Trust Inc. raised its stake in shares of Masimo by 56.3% in the fourth quarter. Blue Trust Inc. now owns 197 shares of the medical equipment provider’s stock valued at $33,000 after acquiring an additional 71 shares during the period. Finally, EverSource Wealth Advisors LLC raised its stake in shares of Masimo by 40.0% in the fourth quarter. EverSource Wealth Advisors LLC now owns 224 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 64 shares during the period. 85.96% of the stock is owned by hedge funds and other institutional investors.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.